.css-1xsl8rf{width:100%;display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-align-items:center;-webkit-box-align:center;-ms-flex-align:center;align-items:center;position:relative;overflow:hidden;background:var(--alert-bg);-webkit-padding-start:var(--chakra-space-4);padding-inline-start:var(--chakra-space-4);-webkit-padding-end:var(--chakra-space-4);padding-inline-end:var(--chakra-space-4);padding-top:var(--chakra-space-1);padding-bottom:var(--chakra-space-1);--alert-fg:var(--chakra-colors-orange-600);--alert-bg:var(--chakra-colors-orange-100);font-weight:var(--chakra-fontWeights-semibold);padding-left:var(--chakra-space-4);}.chakra-ui-dark .css-1xsl8rf:not([data-theme]),[data-theme=dark] .css-1xsl8rf:not([data-theme]),.css-1xsl8rf[data-theme=dark]{--alert-fg:var(--chakra-colors-orange-200);--alert-bg:rgba(251, 211, 141, 0.16);}@media screen and (min-width: 48em){.css-1xsl8rf{padding-left:var(--chakra-space-8);}}Bitte aktivieren Sie Javascript um alle Funktionen nutzen zu können und ihre Nutzererfahrung zu verbessern.

Dr. Patrick Behrendt

Weitere Beteiligungen

28.03.2023
Poster
P 416
Epidermal growth factor receptor modulates Hepatitis E virus entry in human hepatocytes
Host cell factors and modulation, Virus receptors and entry
28.03.2023
Poster
P 072
NRF2 activators inhibit hepatitis E virus propagation in vitro
Clinical virology
28.03.2023
Poster
P 311
Vaccine to inhibit autochthonous transmission of Hepatitis E (VaccinATE)
Adaptive immunity, Vaccines
28.03.2023
Poster
P 090
Hyper-EINS – a tool for automated identification of insertions in the hepatitis E virus hypervariable region
Diagnostic methods and tools, Viral replication strategies 1 (RNA viruses)
28.03.2023
17:45 – 18:00 12 Min. 3 Min.
Abstract Talk
O 031
Identification of resistance-associated variants after sofosbuvir treatment in chronic hepatitis E patients
Clinical virology